menu search

Marinus pharmaceuticals to provide business update and report first quarter 2023 financial results on may 11, 2023

RADNOR, Pa.--(BUSINESS WIRE)--Marinus pharmaceuticals, Inc. (Nasdaq: MRNS), a ...

April 27, 2023, 7:01 am

Kalvista pharmaceuticals to present data at the 13th c1-inhibitor deficiency & angioedema workshop

CAMBRIDGE, Mass. & SALISBURY, England--(BUSINESS WIRE)---- $KALV--KalVista pharmaceuticals, Inc. (NASDA...

April 27, 2023, 6:30 am

Rigel pharmaceuticals q1 preview: a 2-drug company pushing for profitability

Rigel pharmaceuticals Q1 Preview: A 2-Drug Company Pushing For Profitability....

April 27, 2023, 3:27 am

Biomarin pharmaceutical (bmrn) q1 earnings and revenues surpass estimates

BioMarin pharmaceutical (BMRN) came out with quarterly earnings of $0.60 per share, beating the Zacks C...

April 26, 2023, 6:59 pm

Pharmacovigilance market to exhibit usd 11.5 bn by 2028, expanding at an 8.8% cagr, says transparency market research

Global pharmacovigilance industry growth is driven by the demand for routine medication monitoring has increased along with rising drug usage and the ...

April 26, 2023, 6:30 pm

Arbutus biopharma clinical hold slows hepatitis b momentum: broker

Analysts at Baird Equity Research have awarded Arbutus Biopharma a ‘Neutral' rating after the early-stage bio...

April 26, 2023, 2:44 pm

Cullinan oncology to present first clinical data evaluating novel anti-mica/b antibody, cln-619, in patients with advanced solid tumors at asco 2023

CAMBRIDGE, Mass., April 26, 2023 (GLOBE NEWSWIRE) — Cullinan Oncology, Inc. (Nasdaq: CGEM), a biopharmaceuti...

April 26, 2023, 2:08 pm

Galera to present one-year reductions in cisplatin-related chronic kidney disease data from roman trial at 2023 american society of clinical oncology (asco) annual meeting

MALVERN, Pa., April 26, 2023 (GLOBE NEWSWIRE) — Galera Therapeutics, Inc. (Nasdaq: GRTX), a clinical-stage bio...

April 26, 2023, 2:00 pm

Zyversa therapeutics, inc. announces pricing of $11.0 million public offering

WESTON, Fla., April 26, 2023 (GLOBE NEWSWIRE) — ZyVersa Therapeutics, Inc. (Nasdaq: ZVSA, or “ZyVersa”), a clinical stage specialty bio...

April 26, 2023, 1:10 pm

60 degrees pharmaceuticals awarded u.s. patent covering tafenoquine for treatment of covid-19 and other lung infections

Patent provides exclusive use through 2040 of tafenoquine for treatment of COVID-19 and other lung infections. Tafenoquine is the active molecule in 6...

April 26, 2023, 11:34 am

Are medical stocks lagging amphastar pharmaceuticals (amph) this year?

Here is how Amphastar pharmaceuticals (AMPH) and Addus HomeCare (ADUS) have performed compared to their...

April 26, 2023, 11:28 am

Autolus therapeutics announces data from auto1/22 trial in pediatric acute lymphoblastic leukemia in an oral presentation at the ebmt 49th annual meeting

– Data support utility of AUTO1/22 approach in preventing antigen evasion in pediatric B-ALL – Complete responses observed in patients with CD19 n...

April 26, 2023, 11:06 am

Gracell biotechnologies to present updated clinical data on bcma/cd19 dual-targeting fastcar-t gc012f at 2023 asco annual meeting

SAN DIEGO, Calif., and SUZHOU and SHANGHAI, China , April 26, 2023 /PRNewswire/ -- Gracell Biotechnologies Inc. ("Gracell" or the "Company", NASDAQ: G...

April 26, 2023, 10:15 am

Cullinan oncology to present first clinical data evaluating novel anti-mica/b antibody, cln-619, in patients with advanced solid tumors at asco 2023

CAMBRIDGE, Mass., April 26, 2023 (GLOBE NEWSWIRE) -- Cullinan Oncology, Inc. (Nasdaq: CGEM), a biopharmaceuti...

April 26, 2023, 10:08 am

X4 pharmaceuticals to report first-quarter 2023 financial results and host a conference call and webcast on may 4, 2023

BOSTON, April 26, 2023 (GLOBE NEWSWIRE) -- X4 pharmaceuticals, Inc. (Nasdaq: XFOR), a leader in the dis...

April 26, 2023, 8:01 am

Achieve life sciences to announce first quarter 2023 financial results and host conference call and webcast on may 9, 2023

SEATTLE and VANCOUVER, British Columbia, April 26, 2023 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (NASDAQ: ACHV), a late-stage clinical ...

April 26, 2023, 8:00 am

Gsk earnings beat expectations. race for rsv vaccine leads pipeline hopes.

The pharmaceutical company is vying to bring the first shot for respiratory syncytial virus to market....

April 26, 2023, 4:46 am

Global painkillers market is predicted to be worth us$ 100.9 billion, and grow at a cagr of 3.7% by the end of the year 2033 | data by future market insights, inc.

Demand for Painkillers in Western Europe is Expected to Register a Growth of 3.3% Over the Next Ten Years. Pfizer Inc., Janssen ...

April 26, 2023, 1:30 am

Teva pharmaceutical is stabilizing hinting a payoff potential

Teva pharmaceutical Is Stabilizing Hinting A Payoff Potential....

April 25, 2023, 9:59 pm

Octyl salicylate market is expected to reach $1.8 billion by 2030, grow at a cagr of 5.4% during forecast period 2023 to 2030 | data by contrive datum insights pvt ltd.

According to a market research study published by Contrive Datum Insights, The cosmetics, pharmaceutical...

April 25, 2023, 8:36 pm


Search within

Pages Search Results: